Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients
- 4 October 2021
- journal article
- letter
- Published by Elsevier BV in Kidney International
- Vol. 100 (6), 1337-1340
- https://doi.org/10.1016/j.kint.2021.09.014
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant RecipientsThe New England Journal of Medicine, 2021
- Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis PatientsJournal of the American Society of Nephrology, 2021
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant RecipientsThe New England Journal of Medicine, 2021
- Occurrence of severe COVID-19 in vaccinated transplant patientsKidney International, 2021